Morgan Stanley’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32M Buy
750,750
+96,272
+15% +$3.46M ﹤0.01% 2664
2026
Q1
$21M Buy
654,478
+8,897
+1% +$327K ﹤0.01% 2910
2025
Q4
$24.8M Buy
645,581
+147,743
+30% +$3.24M ﹤0.01% 2728
2025
Q3
$6.84M Sell
497,838
-382,745
-43% -$4.49M ﹤0.01% 3892
2025
Q2
$11.4M Sell
880,583
-58,513
-6% -$608K ﹤0.01% 3315
2025
Q1
$10.6M Sell
939,096
-207,515
-18% -$2.72M ﹤0.01% 3286
2024
Q4
$15M Buy
1,146,611
+563,552
+97% +$14.5M ﹤0.01% 3031
2024
Q3
$23.3M Buy
583,059
+179,837
+45% +$6.54M ﹤0.01% 2652
2024
Q2
$11.9M Buy
+403,222
New +$11M ﹤0.01% 3180

Other funds holding PACS

Morgan Stanley's PACS Position: Q2 2026 in Review

Morgan Stanley increased its PACS Group (PACS) stake by 15% in Q2 2026, buying an estimated $3.46M and bringing the position to 750,750 shares worth $32M. The position accounts for ﹤0.01% of the portfolio, ranked #2664.

Morgan Stanley first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Morgan Stanley held 750,750 shares of PACS Group worth $32M as of Q2 2026.
  • Morgan Stanley bought 96,272 PACS Group shares in Q2 2026, an estimated $3.46M.
  • PACS Group made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2664 holding.
  • Morgan Stanley first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.